C07C 233/76
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
C07C233/76 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 93 US grants and 98 published applications in this corpus.
Search patents in C07C- Granted patents
- 93
- Published applications
- 98
- Assignees
- 71
- Inventors
- 377
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 3 |
| 2003 | 2 | 5 |
| 2004 | 0 | 8 |
| 2005 | 1 | 1 |
| 2006 | 2 | 4 |
| 2007 | 4 | 3 |
| 2008 | 3 | 2 |
| 2009 | 2 | 3 |
| 2010 | 5 | 3 |
| 2011 | 1 | 3 |
| 2012 | 3 | 2 |
| 2013 | 1 | 0 |
| 2014 | 3 | 9 |
| 2015 | 3 | 3 |
| 2016 | 6 | 13 |
| 2017 | 9 | 5 |
| 2018 | 2 | 4 |
| 2019 | 7 | 0 |
| 2020 | 1 | 9 |
| 2021 | 4 | 2 |
| 2022 | 4 | 5 |
| 2023 | 1 | 3 |
| 2024 | 2 | 5 |
| 2025 | 3 | 1 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-inflammatory compounds19 May 2026US 12,630,493 B2
- EP2 antagonist19 May 2026US 12,630,510 B2Ono Pharmaceutical Co., Ltd.
- PCNA inhibitors7 Oct 2025US 12,435,030 B2City of Hope
- Compounds5 Aug 2025US 12,377,105 B2TMEM16A Limited
- Cyclic diones as herbicidal compounds3 Jun 2025US 12,319,640 B2Syngenta Crop Protection AG
- Anti-inflammatory compounds6 Aug 2026US 2026/0225985 A1
- Compounds28 May 2026US 2026/0144743 A1TMEM16A Limited
- Benzamide enaminone derivatives and methods of use thereof25 Sep 2025US 2025/0296910 A1
- Enzyme inhibitors and viral infection therapy26 Dec 2024US 2024/0425473 A2University of Southern California
- Pcna inhibitors17 Oct 2024US 2024/0343682 A1City of Hope
Most cited
By later US patents
- Trisubstituted carbocyclic cyclophilin binding compounds and their use56US 6,656,971 B2Guilford Pharmaceuticals Inc. · 2003
- N-acetonylbenzamides and their use as fungicides53US 5,304,572 ARohm and Haas Company · 1994
- Benzofuran derivatives useful as inhibitors of bone resorption46US 5,858,995 AFujisawa Pharmaceutical Co., Ltd. · 1999
- Aniline derivatives or salts thereof and cytokine production inhibitors containing the same46US 7,132,546 B2Ishihara Sangyo Kaisha, Ltd. · 2006
- Mammalian DNA topoisomerase II inhibitor and method45US 5,426,224 AThe University of North Carolina at Chapel Hill · 1995